AwardedSpainGoods€152,292,577
Suministro de forma centralizada de medicamentos de uso humano para el tratamiento de la fibrosis quística que contiene los principios activos siguientes: IVACAFTOR, LUMACAFTOR + IVACAFTOR, TEZACAFTOR + IVACAFTOR Y LEXACAFTOR + IVACAFTOR +TEZACAFTOR con destino a los centros del ámbito de la sanidad pública valenciana.
- Published
- Published 24 June 2026
Overview
The Valencian Public Health Authority has awarded a centralized supply contract for cystic fibrosis medications containing ivacaftor, lumacaftor + ivacaftor, tezacaftor + ivacaftor, and lexacaftor + ivacaftor + tezacaftor to Vertex Pharmaceuticals Spain SL. The contract, valued at approximately 152.3 million EUR, supplies these pharmaceutical products to public healthcare facilities across the Valencia region.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €152,292,577
- Procedure
- Direct
- Published
- 24 June 2026
Medical equipments, pharmaceuticals and personal care productsMedicinal products for the respiratory system
Award outcome
- Awarded value
- €0
- Award date
- 21 May 2026
- Vertex Pharmaceuticals Spain SL,
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
24 June 2026
Contracting authority
Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad
Procuring entityValencia, Spain
ID_PLATAFORMA: 20897030133463
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.